TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE B Andemariam; A Inati; R Colombatti; C Minniti; C Brown; M Hottmann; S Gray; C Hoppe; F Montealegre-Golcher; P Yue;

DEVELOPMENT OF A TREATMENT DECISION-MAKING TOOL FOR SICKLE CELL DISEASE MANAGEMENT: THE MANAGE, MONITOR, REALIZE FRAMEWORK F Bernaudin; AA Zayed; KA Anie; ME Fields; ES Klings; C Lobo; O Mboma; SL Saraf; F Montealegre-Golcher; W Smith;

PRELIMINARY RESULTS FROM A MULTICENTER PHASE 2/3 STUDY OF NEXT-GENERATION SICKLE HEMOGLOBIN POLYMERIZATION INHIBITOR OSIVELOTOR (GBT021601) FOR THE TREATMENT OF PATIENTS WITH SICKLE CELL DISEASE SL Saraf; SU Abdullahi; AM Akinsete; FA Fasola; M Idowu; S Pennington; WB Ershler; MP Stagg; EA Lisbon; F Montealegre-Golcher;